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Abstract
Background: Pancreatic cancer is one of the most aggressive human tumors due to its high potential of local
invasion and metastasis. The aim of this study was to characterize the membrane proteomes of pancreatic ductal
adenocarcinoma (PDAC) cells of primary and metastatic origins, and to identify potential target proteins related to
metastasis of pancreatic cancer.
Methods: Membrane/membrane-associated proteins were isolated from AsPC-1 and BxPC-3 cells and identified
with a proteomic approach based on SDS-PAGE, in-gel tryptic digestion and liquid chromatography with tandem
mass spectrometry (LC-MS/MS). X! Tandem was used for database searching against the SwissProt human protein
database.
Results: We identified 221 & 208 proteins from AsPC-1 and BxPC-3 cells, respectively, most of which are
membrane or membrane-associated proteins. A hundred and nine proteins were found in both cell lines while the
others were present in either AsPC-1 or BxPC-3 cells. Differentially expressed proteins between two cell lines
include modulators of cell adhesion, cell motility or tumor invasion as well as metabolic enzymes involved in
glycolysis, tricarboxylic acid cycle, or nucleotide/lipid metabolism.
Conclusion: Membrane proteomes of AsPC-1 (metastatic) and BxPC-3 (primary) cells are remarkably different. The
differentially expressed membrane proteins may serve as potential targets for diagnostic and therapeutic
interventions.
Introduction
Pancreatic cancer is one of the most aggressive human
malignancies. Despite the advances in therapeutic strate-
gies including surgical techniques as well as local and
systemic adjuvant therapies, the overall survival in
patients with pancreatic cancer remains dismal and has
not improved substantially over the past 30 years. Med-
ian survival from diagnosis is typically around 3 to
6 months, and the 5-year survival rate is less than 5%.
As a result, in 2003, pancreatic cancer surpassed pros-
tate cancer as the 4
th leading cause of cancer-related
death in the US [1]. The main reason for the failure of
current conventional therapy to cure pancreatic cancer
and the major cause for cancer-related mortality in gen-
eral, is the ability of malignant cells to detach from the
primary tumor site and to develop metastasis in
different regions of the same organ and in distant
organs [2,3]. Pancreatic cancer usually causes no symp-
toms early on, leading to locally advanced or metastatic
disease at time of diagnosis [4]. In this regard, it is
important to identify the functional proteins that regu-
late/promote metastasis in pancreatic cancer. This
would facilitate the development of strategies for thera-
peutic interventions and improved management of
cancer patients.
The purpose of this study is to compare the membrane
proteins expressed in pancreatic cancer cells of primary
and metastatic origins using a proteomics approach. Mem-
brane proteomics can be defined as analysis and character-
ization of entire complement of membrane proteins
present in a cell under a specific biological condition [5,6].
In fact, membrane proteins account for more than two-
thirds of currently known drug targets. Defining
membrane proteomes is therefore important for finding
potential drug targets. Membrane proteomics can also
serve as a promising approach to human cancer biomarker
* Correspondence: shenhu@ucla.edu
1UCLA School of Dentistry & Dental Research Institute, Los Angeles, CA,
90095, USA
Full list of author information is available at the end of the article
Liu et al. Journal of Biomedical Science 2010, 17:74
http://www.jbiomedsci.com/content/17/1/74
© 2010 Liu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.discovery because membrane proteins are known to have
implication in cell proliferation, cell adhesion, cell motility
and tumor cell invasion [7-9].
Materials and methods
Cell culture
AsPC-1 and BxPC-3 cell lines were obtained from
American Tissue Culture Collection (ATCC, Rockville,
MD). These cell lines were initially generated from
patients with pancreatic ductal adenocarcinoma (PDAC)
[10-12]. The cells were maintained at 5% CO2-95% air,
37°C, and with RPMI 1640 (ATCC) containing 10% FBS,
100 μg/ml penicillin G and 100 mg/ml streptomycin.
When the confluence reached 80-90%, the cells were
harvested and washed with PBS for three times.
Sample preparation
Membrane proteins from AsPC-1 and BxPC-3 cells were
isolated with the ProteoExtract Native Membrane Pro-
tein Extraction Kit (EMD Chemicals, Gibbstown, NJ). In
brief, the cell pellet was washed three times with the
Washing Buffer, and then incubated with ice-cold
Extract Buffer |at 4°C for 10 min under gentle agitation.
After the pellet was centrifuged at 16,000 g for 15 min
(4°C), the supernatant was discarded and 1 mL ice-cold
Extract Buffer|| was added to the pellet. This membrane
protein extraction step was allowed for 30 min at 4°C
under gentle agitation. Then the supernatant was
collected after centrifugation at 16,000 g for 15 min 4°C.
SDS-PAGE and proteolytic cleavage
Total membrane protein concentration was measured
with the 2-D Quant Kit (GE Healthcare, Piscataway, NJ).
In total, 20 μg of membrane proteins from each cell line
were loaded into a 4-12% NuPAGE Bis-Tris gel (Invitro-
gen, Carlsbad, CA) for SDS-PAGE separation. The gel
was stained with the Simply Blue staining solution (Invi-
trogen) to visualize the proteins. Each gel was then cut
into 15 sections evenly and proteolytic cleavage of pro-
teins in each section was performed with enzyme-grade
trypsin (Promega, Madison, WI) as previously described.
Tandem MS and database searching
Liquid chromatography (LC) with tandem MS (LC/MS/
MS) of peptides was performed using a NanoLC system
(Eksigent Technologies, Dublin, CA) and a LTQ mass
spectrometer (Thermo Fisher, Waltham, MA). Aliquots
(5 μL) of the peptide digest derived from each gel slice
were injected using an autosampler at a flow rate of 3.5
μL/min. The peptides were concentrated and desalted
on a C18 IntegraFrit Nano-Precolumn (New Objective,
Woburn, MA) for 10 min, then eluted and resolved
using a C18 reversed-phase capillary column (New
Objective). LC separation was performed at 400 nL/min
with the following mobile phases: A, 5% acetonitrile/
0.1%formic acid (v/v); B, 95% acetonitrile/0.1% formic
acid (v/v). The chosen LC gradient was: from 5% to 15%
B in 1 min, from 15% to 100% B in 40 min, and then
maintained at 100%B for 15 min.
Database searches were performed using the X! Tandem
search engine against the SwissProt protein sequence data-
base. The search criteria were set with a mass accuracy of
0.4 Da and semi-style cleavage by trypsin. Proteins with
two unique peptides are considered as positively identified.
Western blot analysis
AsPC-1 and BxPC-3 cells were lysed with a lysis buffer
containing 8 M urea, 2 M Thiourea and 4% CHAPS.
Cell lysates with a total protein amount of 40 μgw e r e
separated with 8-12% NuPAGE gels at 100 V for about
2 hours and then transferred to polyvinylidene difluoride
membrane using an iBlot system (Invitrogen, Carlsbad,
CA, USA). After saturating with 2% slim milk, the blots
were sequentially incubated with primary antibody
(1:100 dilution) and horseradish peroxidase-conjugated
a n t i m o u s eI g Gs e c o n d a r ya n t i b o d y( 1 : 1 0 0 0d i l u t i o n ,
Applied Biological Materials Inc, Richmond, Canada).
Anti-annexin A1 was obtained from Abcam (Cambridge,
MA, USA) whereas anti-phosphoglycerate kinase 1 was
obtained from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Finally, the bands were visualized by
enhanced chemiluminescence detection (Applied Biolo-
gical Materials).
Results
The purpose of this study was to demonstrate a mem-
brane proteomic analysis of PDAC cells and to identify
differentially expressed membrane proteins between pri-
mary and metastatic PDAC cells, which may have a
potential role in metastasis of pancreatic cancer. Two
PDAC cell lines, AsPC-1 and BxPC-3, were used in this
study. AsPC-1 is a cell line of metastatic origin from a
62 year-old female Caucasian whereas BxPC-3 is a cell
line of primary PDAC from a 61 year-old female Cauca-
sian [10-12]. Membrane proteins of AsPC-1 and BxPC-3
cells were isolated and then resolved with SDS-PAGE
(Figure 1A). Proteins in each gel slices were proteolyti-
cally cleaved and the resulting peptides were analyzed
with LC-MS/MS. In total, we identified 221 and 208
membrane or membrane-associated proteins from
AsPC-1 and BxPC-3 cells, respectively, based on at least
2 unique peptides. A hundred and nine proteins were
present in both cell lines but others were only found in
AsPC-1 or in BxPC-3 cells (Figure 1B). All the identified
proteins and matched peptides from the two cell lines
are summarized in Additional file 1, Tables S1 and S2.
Proteins with single matched peptide were not tabulated
although previous publications reported identification of
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[13,14]. The identified proteins were then sorted accord-
ing to the Gene Ontology Annotation database
(Figure 2). A hundred and four proteins were assigned
as membrane proteins in AsPC-1 cells whereas 101 pro-
teins were assigned as membrane proteins in BxPC-3
cells. Table 1 lists the “integral to membrane” proteins
found in AsPC-1 and BxPC-3 cells. Besides the mem-
brane proteins, the proteomic analysis also identified
many membrane-associated proteins, e.g., extracellular
matrix (ECM) proteins. To confirm the proteomic find-
ing, we verified the differential levels of Annexin A1 and
PGK1 between AsPC-1 and BxPC-3 cells using Western
blotting (Figure 3). Annexin A1 was found to be over-
expressed in BxPC-3 cells whereas phosphoglycerate
kinase 1 was over-expressed in AsPC-1 cells, which
agrees to the results obtained by the proteomic
approach.
Discussion
Metastasis is a highly organ-specific process, which
requires multiple steps and interactions between tumor
cells and the host. These include detachment of tumor
cells from the primary tumor, intravasation into lymph
and blood vessels, survival in the circulation, extravasa-
tion into target organs, and subsequent proliferation and
induction of angiogenesis. Many proteins are critically
involved in this process, such as cell-cell adhesion mole-
cules (CAMs), members of the cadherins and, integrins,
metalloproteinases (MMPs) and the urokinase plasmino-
gen activator/urokinase plasminogen activator receptor
(uPA/uPAR) system. As modulators of metastatic
growth, these molecules can affect the local ECM,
stimulate cell migration, and promote cell proliferation
and tumor cell survivals [15]. Furthermore, hypoxia can
drive genomic instability and lead to a more aggressive
tumor phenotype [16,17], which may partially explain
the highly metastatic nature of PDAC [18]. Last but not
least, angiogenesis plays a critical role in invasion and
metastasis in terms of tumor cell dissemination. Based
on these new insights in mechanism of tumor invasion
and metastasis, novel therapies are currently investigated
for therapy of patients with pancreatic cancer [19-21].
Nevertheless, proteomic analysis of primary and meta-
static PDAC is required to reveal additional functional
proteins that regulate or promote tumor metastasis, as
detailed in previous studies [22-24]. These signature
molecules are predictors of metastatic risk and also pro-
vide a basis for the development of anti-metastatic
therapy.
Our proteomic analysis has revealed a large number of
differentially expressed membrane/surface proteins
between metastatic and primary PDAC cells, and the
validity of such a proteomic approach has been verified
by Western blot analysis. In fact, the differential expres-
sion of membrane proteins between AsPC-1 and BxPC-
3 can be observed from the SDS-PAGE patterns of
membrane proteins from the two cell lines (Figure 1).
The proteins showing differential levels include cadher-
ins, catenin, integrins, galectins, annexins, collagens and
many others, which are known to have roles in tumor
cell adhesion or motility. Cadherins are a class of type-1
transmembrane proteins that depend on calcium ions to
f u n c t i o n .T h e yp l a yi m p o r t a n tr o l e si nc e l la d h e s i o n ,
ensuring that cells are bound together within tissues.
Catenins, which are proteins found in complexes with
cadherins, also mediate cell adhesion. Our study identi-
fied cadherins (protocadherin-16 and protocadherin
alpha-12) and alpha-2 catenin in primary tumor cells
(BxPC-3) but not in metastatic tumor cells (AsPC-1),
suggesting a defect in cell-to-cell adhesion in metastatic
AcPC-1 cells.
Integrins are members of a glycoprotein family that
form heterodimeric receptors for ECM molecules. These
proteins are involved in an adhesive function, and they
provide traction for movement in cell motility [25]. In
total, there are 18 a-subunits and 8 b-subunits, which
a r ep a i r e dt of o r m2 4d i f f e r e n ti n t e g r i n st h r o u g hn o n -
covalent bonding. Among these proteins, integrin-b1, a2,
a5,a n da6 represent major adhesion molecules for the
adhesion of pancreatic cancer cells to ECM proteins
[26]. In our study, integrin-b1 and integrin-b4 was found
in both tumor cell lines while integrin a2 and a5 only
identified in BxPC-3 cells. Collagens are major ECM
proteins. Cell surface-expressed portion of collagens
Figure 1 Analysis and identification of membrane proteins in
AsPC-1 and BxPC-3 cells using a proteomics approach based on
SDS-PAGE, in-gel digestion and LC-MS/MS. (A) Membrane
proteins were isolated, separated with SDS-PAGE and detected with
Simply Blue stain. The gel bands were then excised and digested
with trypsin, and the resulting peptides were extracted for LC-MS/MS
analysis. (B) 221 and 208 proteins were identified from AsPC-1 and
BxPC-3 cells, respectively, with 109 proteins present in both cell lines.
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adhesion. Twelve members of collagen family were
found in the BxPC-3 cells whereas only four members
found in AsPC-1 cells.
Conversely, galectin-3 and galectin-4 were found in
AsPC-1 but not in BxPC-3 cells. Galectins are carbohy-
drate-binding proteins and have an extremely high affinity
for galactosides on cell surface and extracellular glycopro-
teins. Galectins, especially galectin-3, are modulators of
cancer cell adhesion and invasiveness. Galectin-3 usually
exists in cytoplasm, but can be secreted and bound on the
c e l ls u r f a c eb yav a r i e t yo fg l ycoconjugate ligands. Once
localized to the cell surface, galectin-3 is capable of oligo-
merization, and the resultant cross-linking of surface
glycoproteins into multimolecular complexes on the
endothelial cell surface is reported to mediate the adhesion
of tumor cells to the vascular endothelium [27]. Lyso-
some-associated membrane glycoprotein 1 (LAMP1) is a
receptor for galectin-3, and was found on the cell surface
of highly metastatic tumor cells [28]. Our study revealed
LAMP1 in AsPC-1 cells but not in BxPC-3 cells. The cell
surface-expressed portion of LAMP1 maybe serve as a
ligand for galectin 3, mediating cell-cell adhesion and
indirectly tumor spread. FKBP12-rapamycin complex-
associated protein (a.k.a., mTOR) was also identified in
AsPC-1 cells but not in BxPC-3 cells. mTOR is a down-
stream serine/threonine protein kinase of the phosphatidy-
linositol 3-kinase/Akt pathway that regulates cell
proliferation, cell motility, cell survival, protein synthesis,
and transcription. Rapamycin, a specific inhibitor of
mTOR, suppresses lymphangiogenesis and lymphatic
metastasis in PDAC cells [29].
The described proteomic approach is reproducible for
analysis of membrane proteins in cultured pancreatic
cancer cells. We observed consistent SDS-PAGE gel pat-
terns for membrane proteins isolated from cultured
AsPC-1 or BxPC-3 cells. To examine the reproducibility
of LC-MS/MS for identification of membrane proteins,
we repeated LC-MS/MS analysis of the peptides yielded
from 3 gel bands. Compared to single LC-MS/MS,
which identified 45 proteins in total, the duplicate LC-
MS/MS analyses identified 47 proteins (~4% increase).
Figure 2 Sorting of the identified proteins according to their subcellular localization.
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brane protein profiles between the two PDAC cell lines
is meaningful. Our adopted approach is valid to identify
large membrane proteins, which are usually difficult to
analyze with 2-D gel electrophoresis (2-DE) method. In
AsPC-1 cells, 35% of the identified proteins have a
molecular weight above 70 kDa, whereas 43% of the
proteins are larger than 70 kDa in BxPC-3 cells. In addi-
tion to the proteins either present in AsPC-1 or in
BxPC-3 cells, many other proteins were found in both
cell types with a differential number of peptides
matched. This may reflect the differential level of a
Table 1 Integral to membrane proteins identified in AsPC-1 & BxPC-3 cells
AsPC-1 BxPC-3
Accession # Protein name Accession # Protein name
1A25_HUMAN HLA class I histocompatibility antigen, A-25 alpha chain 4F2_HUMAN 4F2 cell-surface antigen heavy chain
4F2_HUMAN 4F2 cell-surface antigen heavy chain ACSL3_HUMAN Long-chain-fatty-acid–CoA ligase 3
AAAT_HUMAN Neutral amino acid transporter B(0) ACSL4_HUMAN Long-chain-fatty-acid–CoA ligase 4
ACSL5_HUMAN Long-chain-fatty-acid–CoA ligase 5 ADT2_HUMAN ADP/ATP translocase 2
ADT2_HUMAN ADP/ATP translocase 2 ALK_HUMAN ALK tyrosine kinase receptor precursor
ANPRC_HUMAN Atrial natriuretic peptide clearance receptor APMAP_HUMAN Adipocyte plasma membrane-associated protein
AOFB_HUMAN Amine oxidase [flavin-containing] B AT1A1_HUMAN Sodium/potassium-transporting ATPase subunit alpha-1
APMAP_HUMAN Adipocyte plasma membrane-associated protein CALX_HUMAN Calnexin
AT1A1_HUMAN Sodium/potassium-transporting ATPase subunit alpha-1
precursor
CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion
molecule 1
ATP7B_HUMAN Copper-transporting ATPase 2 CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion
molecule 6
CALX_HUMAN Calnexin CKAP4_HUMAN Cytoskeleton-associated protein 4
CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion
molecule 1
CLCN1_HUMAN Chloride channel protein
CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion
molecule 6
CMC2_HUMAN Calcium-binding mitochondrial carrier protein Aralar2
CMC2_HUMAN Calcium-binding mitochondrial carrier protein Aralar2 CODA1_HUMAN Collagen alpha-1(XIII) chain
CY1_HUMAN Cytochrome c1, heme protein CSMD2_HUMAN CUB and sushi domain-containing protein 2
EGFR_HUMAN Epidermal growth factor receptor precursor EAA1_HUMAN Excitatory amino acid transporter 1
FLNB_HUMAN Filamin-B GP124_HUMAN Probable G-protein coupled receptor 124
FLRT1_HUMAN Leucine-rich repeat transmembrane protein FLRT1 GRP78_HUMAN 78 kDa glucose-regulated protein
FZD8_HUMAN Frizzled-8 precursor HNRPM_HUMAN Heterogeneous nuclear ribonucleoprotein M
GRP78_HUMAN 78 kDa glucose-regulated protein ITAV_HUMAN Integrin alpha-V
IL4RA_HUMAN Interleukin-4 receptor alpha chain KCNQ3_HUMAN Potassium voltage-gated channel subfamily KQT
member 3
IMMT_HUMAN Mitochondrial inner membrane protein L2HDH_HUMAN L-2-hydroxyglutarate dehydrogenase
KCNK3_HUMAN Potassium channel subfamily K member 3 M2OM_HUMAN Mitochondrial 2-oxoglutarate/malate carrier protein
KTN1_HUMAN Kinectin MUC16_HUMAN Mucin-16
LAMP1_HUMAN Lysosome-associated membrane glycoprotein 1 MYOF_HUMAN Myoferlin
LRC59_HUMAN Leucine-rich repeat-containing protein 59 OST48_HUMAN Dolichyl-diphosphooligosaccharide–protein
glycosyltransferase 48 kDa subunit
MTCH2_HUMAN Mitochondrial carrier homolog 2 PCD16_HUMAN Protocadherin-16 precursor
MUC16_HUMAN Mucin-16 PGRC1_HUMAN Membrane-associated progesterone receptor
component 1
MYOF_HUMAN Myoferlin PHB_HUMAN Prohibitin
OST48_HUMAN Dolichyl-diphosphooligosaccharide–protein
glycosyltransferase 48 kDa subunit
PK1L1_HUMAN Polycystic kidney disease protein 1-like 1
PHB_HUMAN Prohibitin PTPRZ_HUMAN Receptor-type tyrosine-protein phosphatase zeta
S12A1_HUMAN Solute carrier family 12 member 1 SSRD_HUMAN Translocon-associated protein subunit delta precursor
SFXN3_HUMAN Sideroflexin-3 TFR1_HUMAN Transferrin receptor protein 1
VAT1_HUMAN Synaptic vesicle membrane protein VAT-1 homolog TMEDA_HUMAN Transmembrane emp24 domain-containing protein 10
VDAC2_HUMAN Voltage-dependent anion-selective channel protein 2 TOM40_HUMAN Mitochondrial import receptor subunit TOM40
homolog
VMAT2_HUMAN Synaptic vesicular amine transporter
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fication is needed. Around 50% of the proteins identified
in AsPC-1 and BxPC-3 cells are directly classified as
membrane proteins, including a number of integral to
membrane proteins and plasma membrane proteins. In
addition, many mitochondrial inner membrane proteins
were also identified from AsPC-1 (n = 21) and BxPC-3
(n = 13) cells. The mitochondrial inner membrane
forms internal compartments known as cristae, which
allow greater space for the proteins such as cytochromes
to function properly and efficiently. The inner mito-
chondrial membrane contains mitochondria fusion and
fission proteins, ATP synthases, transporter proteins
regulating metabolite flux as well as proteins that per-
form the redox reactions of oxidative phosphorylation,
many of which were identified in this study. Among the
proteins that are not classified as membrane proteins,
many are either membrane-associated proteins (e.g.,
kinases, G proteins, or enzymes) or proteins associated
with other subcellular compartments such as mitochon-
dria, endoplasmic reticulum (ER) or nucleus (e.g., his-
tones, elongation factors, translation initiation factor
and transcription factors) (Additional file 1, Table S1). It
is commonly assumed that a protein is predominantly
localized in a given cellular compartment where it exerts
i t ss p e c i f i cf u n c t i o n .H o w e v e r ,as a m ep r o t e i nm a yb e
localized at different cell compartments or travel
between different organelles and therefore exert multiple
cellular functions [30]. In fact, many proteins identified
in mitochondria or ER are membrane or membrane-
associated proteins.
In addition, many metabolic enzymes were identified
from the two PDAC cell lines, reflecting the functional
role of pancreas (Tables 2 and 3). These metabolic
enzymes are involved in glycolysis, tricarboxylic acid
cycle, gluconeogenesis, metabolism of nucleotides,
lipids/fatty acids and amino acids, protein folding/
unfolded protein response, and pantose phosphate
shunt. Table 4 lists the small, membrane associated G
proteins identified in AsPC-1 and BxPC-3 cells. Small
GTPases regulate a wide variety of cellular processes,
including growth, cellular differentiation, cell movement
and lipid vesicle transport. RhoA, Rab-1A and Rab-10
were present in AsPC-1 cells whereas Rab-14 was found
in BxPC-3 cells. As a proto-oncogene, RhoA regulates a
signal transduction pathway linking plasma membrane
receptors to the assembly of focal adhesions and actin
stress fibers. On the other hand, Rab-1A regulates the
‘ER-to-Golgi’ transport, a bidirectional membrane traffic
between the ER and Golgi apparatus which mediates the
transfer of proteins by means of small vesicles or tubu-
lar-saccular extensions. Rab-10 is also involved in vesi-
cular trafficking, particularly the directed movement of
substances from the Golgi to early sorting endosomes.
Mutated KRAS is a potent oncogene in PDAC. KRAS
protein is usually tethered to cell membranes because of
t h ep r e s e n c eo fa ni s o p r e n y lg r o u po ni t sC - t e r m i n u s .
However, KRAS protein was not identified in this study,
which might result from numerous mutations of the
gene, hindering the matching of peptides based on
molecular weight.
Some of the proteins identified from the current study
may be further verified in clinical specimens as biomarkers
for diagnostic/prognostic applications. Particularly, protein
biomarkers may be used to classify pancreatic cancer
patients for a better treatment decision. Cancer biomarker
discovery is an intensive research area. Despite the fact
that a large number of researchers are searching for cancer
biomarkers, only a handful of protein biomarkers have
been approved by the US Food and Drug Administration
(FDA) for clinical use [31]. Interestingly, most of the FDA-
approved protein biomarkers for human cancers are mem-
brane proteins, including cancer antigen CA125 (ovarian),
carcinoembryonic antigen (colon), epidermal growth fac-
tor receptor (colon), tyrosine-protein kinase KIT (gastroin-
testinal), HER2/NEU, CA15-3, CA27-29, Oestrogen
receptor and progesterone receptor (breast) and bladder
tumour-associated antigen (bladder) [31]. Similarly, most
of the reported protein biomarkers in PDAC are of mem-
brane origin or membrane-associated, including CA 19-9,
CEA, CA 242, CA 72-4, KRAS, KAI1, CEA-related cell
adhesion molecule 1 (CEACAM1), MUC1, MUC4, among
many others [32-39]. For instance, CA 19-9 is a membrane
carbohydrate antigen and the most commonly used bio-
marker in pancreatic cancers. As a cell adhesion molecule,
CEA actually mediates the collagen binding of epithelial
cells [40]. KAI1, a metastasis suppressor protein, belongs
to the transmembrane 4 superfamily. It is up-regulated in
early PDAC and down-regulated in metastatic PDAC [34].
The present study also identified CEA-related cell
Figure 3 Western blot analysis of Annexin A1 and
phosphoglycerate kinase 1 (PGK1) between AsPC-1 and BxPC-3
cells.
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Protein name Accession # Unique
peptides
Total
peptides
Mr
(Kda)
PI Biological process
2-oxoglutarate dehydrogenase E1 component,
mitochondrial precursor
ODO1_HUMAN 8 18 115.9 6.39 Glycolysis
3,2-trans-enoyl-CoA isomerase, mitochondrial
precursor
D3D2_HUMAN 3 13 32.8 8.8 Fatty acid metabolism; Lipid metabolism
3-hydroxyacyl-CoA dehydrogenase type-2 HCD2_HUMAN 6 10 26.9 7.65 Lipid metabolic process; tRNA processing
3-hydroxyisobutyrate dehydrogenase,
mitochondrial precursor
3HIDH_HUMAN 7 16 35.3 8.38 Pentose-phosphate shunt; valine metabolic
process
3-ketoacyl-CoA thiolase, peroxisomal precursor THIK_HUMAN 3 4 44.3 8.76 Fatty acid metabolism; Lipid metabolism
3-mercaptopyruvate sulfurtransferase THTM_HUMAN 3 7 33.2 6.13 Cyanate catabolic process
78 kDa glucose-regulated protein GRP78_HUMAN 7 12 72.3 5.07 ER-associated protein catabolic process; ER
unfolded protein response; ER regulation of
protein folding
Acetyl-CoA acetyltransferase, mitochondrial
precursor
THIL_HUMAN 2 6 45.2 8.98 Ketone body metabolism
Aconitate hydratase, mitochondrial ACON_HUMAN 2 3 85.4 7.36 Tricarboxylic acid cycle
Acyl-protein thioesterase 1 LYPA1_HUMAN 2 2 24.7 6.29 Fatty acid metabolism; Lipid metabolism
Adenylate kinase 2, mitochondrial KAD2_HUMAN 7 20 26.5 7.67 Nucleic acid metabolic process
ADP/ATP translocase 2 ADT2_HUMAN 5 11 32.9 9.76 Transmembrane transporter activity
Aldehyde dehydrogenase, mitochondrial ALDH2_HUMAN 3 7 56.3 6.63 Alcohol metabolic process
Alpha-enolase ENOA_HUMAN 2 2 47.1 7.01 Glycolysis
Amine oxidase B AOFB_HUMAN 2 2 58.7 7.2 Oxidation reduction
Aspartate aminotransferase, mitochondrial AATM_HUMAN 4 6 47.4 9.14 Lipid transport
ATP synthase subunit alpha, mitochondrial ATPA_HUMAN 21 52 59.7 9.16 ATP synthesis
ATP synthase subunit d, mitochondrial ATP5H_HUMAN 3 7 18.5 5.21 ATP synthesis; Ion transport
ATP synthase subunit b, mitochondrial AT5F1_HUMAN 2 3 28.9 9.37 ATP synthesis
ATP synthase subunit beta, mitochondrial ATPB_HUMAN 28 95 56.5 5.26 ATP synthesis
ATP synthase subunit f, mitochondrial ATPK_HUMAN 2 2 10.9 9.7 ATP synthesis; Ion transport
ATP synthase subunit gamma, mitochondrial; ATPG_HUMAN 3 6 33 9.23 ATP synthesis; proton transport
ATP synthase subunit O, mitochondrial ATPO_HUMAN 6 11 23.3 9.97 ATP synthesis, ion transport; ATP catabolic
process
Calcium-binding mitochondrial carrier protein
Aralar2
CMC2_HUMAN 7 16 74.1 7.14 Mitochondrial aspartate and glutamate
carrier
Citrate synthase, mitochondrial precursor CISY_HUMAN 2 3 51.7 8.45 Tricarboxylic acid cycle
Cytochrome b5 type B CYB5B_HUMAN 2 4 16.3 4.88 Electron transport
Cytochrome b-c1 complex subunit 1,
mitochondrial
QCR1_HUMAN 6 12 52.6 5.94 Electron transport
Cytochrome b-c1 complex subunit 2,
mitochondrial
QCR2_HUMAN 3 4 48.4 8.74 Aerobic respiration; electron transport
chain; oxidative phosphorylation
Cytochrome c oxidase subunit 2 COX2_HUMAN 2 6 25.5 4.67 Electron transport chain
Cytochrome c1, heme protein, mitochondrial CY1_HUMAN 5 10 35.4 9.15 Electron transport chain
Cytochrome c1, heme protein, mitochondrial CY1_HUMAN 2 3 35.4 9.15 Electron transport chain
D-beta-hydroxybutyrate dehydrogenase,
mitochondrial precursor
BDH_HUMAN 2 3 38.1 9.1 Oxidation reduction
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase,
mitochondrial
ECH1_HUMAN 4 10 35.8 8.16 Fatty acid metabolism; Lipid metabolism
Delta-1-pyrroline-5-carboxylate synthetase P5CS_HUMAN 2 4 87.2 6.66 Amino-acid biosynthesis; Proline
biosynthesis
Dihydrolipoyl dehydrogenase, mitochondrial DLDH_HUMAN 7 16 54.1 7.95 Cell redox homeostasis
Dihydrolipoyllysine-residue acetyltransferase
component of pyruvate dehydrogenase complex,
mitochondrial
ODP2_HUMAN 3 5 65.7 7.96 Glycolysis
Dihydrolipoyllysine-residue succinyltransferase
component of 2-oxoglutarate dehydrogenase
complex, mitochondrial
ODO2_HUMAN 4 7 48.6 9.01 Tricarboxylic acid cycle
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Electron transfer flavoprotein subunit alpha,
mitochondrial
ETFA_HUMAN 2 5 35.1 8.62 Electron transport
Electron transfer flavoprotein subunit beta ETFB_HUMAN 4 6 27.8 8.25 Electron transport
Endoplasmin ENPL_HUMAN 16 28 92.4 4.76 ER-associated protein catabolic process;
protein folding/transport; response to
hypoxia
Enoyl-CoA hydratase, mitochondrial ECHM_HUMAN 9 26 31.4 8.34 Fatty acid metabolism; Lipid metabolism
Glutamate dehydrogenase 1, mitochondrial; DHE3_HUMAN 3 4 61.4 7.66 Glutamate metabolism
Glyceraldehyde-3-phosphate dehydrogenase G3P_HUMAN 5 7 36 8.57 Glycolysis
Glycerol-3-phosphate dehydrogenase,
mitochondrial precursor
GPDM_HUMAN 8 15 80.8 7.23 Glycolysis
Haloacid dehalogenase-like hydrolase domain-
containing protein 3
HDHD3_HUMAN 3 4 28 6.21 Metabolic process phosphoglycolate
phosphatase activity
Histidine triad nucleotide-binding protein 2 HINT2_HUMAN 2 3 17.2 9.2 Lipid synthesis; Steroid biosynthesis
Hyaluronidase-3 HYAL3_HUMAN 2 2 46.5 Carbohydrate metabolic process
Hydroxyacyl-coenzyme A dehydrogenase,
mitochondrial precursor
HCDH_HUMAN 2 4 34.3 8.88 Fatty acid metabolism; Lipid metabolism
Isoleucyl-tRNA synthetase, mitochondrial
precursor
SYIM_HUMAN 5 7 113.7 6.78 Protein biosynthesis
Isovaleryl-CoA dehydrogenase, mitochondrial IVD_HUMAN| 2 2 46.3 8.45 Leucine catabolic process; Oxidation
reduction
L-lactate dehydrogenase A chain LDHA_HUMAN 3 5 36.7 8.84 Glycolysis
Lon protease homolog, mitochondrial LONM_HUMAN 2 2 106.4 6.01 Required for intramitochondrial proteolysis
Long-chain-fatty-acid–CoA ligase 5; ACSL5_HUMAN 2 4 75.9 6.49 Fatty acid metabolism; Lipid metabolism
Malate dehydrogenase, mitochondrial MDHM_HUMAN 3 5 35.5 8.92 Tricarboxylic acid cycle; Glycolysis
Medium-chain specific acyl-CoA dehydrogenase,
mitochondrial
ACADM_HUMAN 2 6 46.6 8.61 Fatty acid metabolism; Lipid metabolism
Mitochondrial carrier homolog 2 MTCH2_HUMAN 3 10 33.3 8.25 Transmembrane transport
Mitochondrial inner membrane protein IMMT_HUMAN 2 2 83.6 6.08 Protein binding; Cell proliferation-inducing
NADH-cytochrome b5 reductase 3 NB5R3_HUMAN 3 3 34.2 7.18 Cholesterol biosynthesis; Lipid/steroid
synthesis
Neutral alpha-glucosidase AB GANAB_HUMAN 6 9 106.8 5.74 Carbohydrate metabolic process
Peptidyl-prolyl cis-trans isomerase A PPIA_HUMAN 2 3 18 7.68 Protein folidng; Interspecies interation
Peroxiredoxin-5 PRDX5_HUMAN 2 5 22 8.85 Cell redox homeostasis
Phosphoenolpyruvate carboxykinase,
mitochondrial
PPCKM_HUMAN 8 18 70.6 7.56 Gluconeogenesis
Phosphoglycerate kinase 1 PGK1_HUMAN 4 7 44.6 8.3 Glycolysis
Protein disulfide-isomerase PDIA1_HUMAN 3 3 57.1 4.76 Cell redox homeostasis
Protein disulfide-isomerase A3 PDIA3_HUMAN 4 7 56.7 5.98 Cell redox homeostasis
Protein disulfide-isomerase A4 PDIA4_HUMAN 2 2 72.9 4.96 Cell redox homeostasis; Protein secretion
Protein disulfide-isomerase A6 PDIA6_HUMAN 2 3 48.1 4.95 Cell redox homeostasis; Protein folding
Protein ETHE1, mitochondrial ETHE1_HUMAN 4 11 27.9 6.35 Metabolic homeostasis in mitochondria
Protein transport protein Sec16A SC16A_HUMAN 2 2 233.4 5.4 ER-Golgi transport; Protein transport
Pyruvate dehydrogenase E1 component alpha
subunit, somatic form
ODPA_HUMAN 2 4 43.3 8.35 Glycolysis
Pyruvate dehydrogenase E1 component subunit
alpha, mitochondrial precursor
ODPAT_HUMAN 3 7 42.9 8.76 Glycolysis
Pyruvate dehydrogenase E1 component subunit
beta, mitochondrial
ODPB_HUMAN 2 3 39.2 6.2 Glycolysis; Tricarboxylic acid cycle
Serine hydroxymethyltransferase, mitochondrial GLYM_HUMAN 12 21 56 8.76 L-serine metabolic process; Glycine
metabolic process; One-carbon metabolic
process
Succinate dehydrogenase flavoprotein subunit,
mitochondrial
DHSA_HUMAN 2 5 72.6 7.06 Electron transport; Tricarboxylic acid cycle
Succinyl-CoA ligase [GDP-forming] beta-chain,
mitochondrial precursor
SUCB2_HUMAN 3 3 46.5 6.15 Succinyl-CoA metabolic process;
Tricarboxylic acid cycle
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Succinyl-CoA ligase [GDP-forming] subunit alpha,
mitochondrial precursor
SUCA_HUMAN 2 5 35 9.01 Tricarboxylic acid cycle
Superoxide dismutase [Mn], mitochondrial SODM_HUMAN 2 5 24.7 8.35 Elimination of radicals
Thioredoxin-dependent peroxide reductase PRDX3_HUMAN 4 10 27.7 7.68 Cell redox homeostasis; Hydrogen peroxide
catabolic process
Thiosulfate sulfurtransferase THTR_HUMAN 2 3 33.4 6.77 Cyanate catabolic process
Trifunctional enzyme subunit alpha,
mitochondrial
ECHA_HUMAN 17 46 82.9 9.16 Fatty acid metabolism; Lipid metabolism
Trifunctional enzyme subunit beta, mitochondrial ECHB_HUMAN 6 12 51.3 9.45 Fatty acid metabolism
Trimethyllysine dioxygenase, mitochondrial TMLH_HUMAN 2 3 49.5 7.64 Carnitine biosynthesis
Very long-chain specific acyl-CoA dehydrogenase,
mitochondrial
ACADV_HUMAN 3 5 70.3 8.92 Fatty acid metabolism; Lipid metabolism
Table 3 Metabolic enzymes identified in BxPC-3 cells
Protein name Accession # Unique
peptides
Total
peptides
Mr
(KDa)
PI Biological process
2-oxoglutarate dehydrogenase E1 component,
mitochondrial
ODO1_HUMAN 4 4 115.9 6.39 Glycolysis
3-ketoacyl-CoA thiolase, mitochondrial THIM_HUMAN 2 4 41.9 8.32 Fatty acid metabolism Lipid metabolism
78 kDa glucose-regulated protein GRP78_HUMAN 31 91 72.3 5.07 ER-associated protein catabolic process ER
unfolded protein response ER regulation of
protein folding
Adenylate kinase 2, mitochondrial KAD2_HUMAN 4 7 26.5 7.67 Nucleotide/nucleic acid metabolic process
ADP/ATP translocase 2 ADT2_HUMAN 2 5 32.9 9.76 Transmembrane transporter activity
Alpha-aminoadipic semialdehyde dehydrogenase AL7A1_HUMAN 2 2 55.3 6.44 Cellular aldehyde metabolic process;
oxidation reduction
Alpha-enolase ENOA_HUMAN 3 5 47.1 7.01 Glycolysis
Annexin A1 ANXA1_HUMAN 4 5 38.7 6.57 Anti-apoptosis; Exocytosis; Lipid metabolic
process
Aspartate aminotransferase, mitochondrial
precursor
AATM_HUMAN 2 7 47.4 9.14 Lipid transport
ATP synthase subunit alpha, mitochondrial ATPA_HUMAN 3 6 59.7 9.16 ATP synthesis
ATP synthase subunit beta, mitochondrial ATPB_HUMAN 4 13 56.5 5.26 ATP synthesis
ATP synthase subunit d, mitochondrial ATP5H_HUMAN 2 4 18.5 5.21 ATP synthesis; Ion transport
ATP synthase subunit gamma, mitochondrial ATPG_HUMAN 2 3 33 9.23 ATP synthesis; Proton transport
ATP synthase subunit O, mitochondrial ATPO_HUMAN 2 3 23.3 9.97 ATP synthesis; Ion transport ATP catabolic
process
Calcium-binding mitochondrial carrier protein
Aralar2
CMC2_HUMAN 2 4 74.1 7.14 Mitochondrial aspartate and glutamate
carrier
Citrate synthase, mitochondrial; CISY_HUMAN 3 5 51.7 8.45 Tricarboxylic acid cycle
Cytochrome b-c1 complex subunit 1,
mitochondrial
QCR1_HUMAN 3 5 52.6 5.94 Electron transport
Cytochrome b-c1 complex subunit 2,
mitochondrial
QCR2_HUMAN 2 2 48.4 8.74 Aerobic respiration; Electron transport
chain; Oxidative phosphorylation
Cytochrome c oxidase subunit 2 COX2_HUMAN 2 4 25.5 4.67 Electron transport chain
Cytochrome c oxidase subunit 5B, mitochondrial
precursor
COX5B_HUMAN 2 2 13.7 9.07 Respiratory gaseous exchange
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase,
mitochondrial precursor
ECH1_HUMAN 2 6 35.8 8.16 Fatty acid metabolism; Lipid metabolism
Delta-1-pyrroline-5-carboxylate synthetase P5CS_HUMAN 2 3 87.2 6.66 Amino-acid biosynthesis; Proline
biosynthesis
Dihydrolipoyl dehydrogenase, mitochondrial DLDH_HUMAN 5 13 54.1 7.95 Cell redox homeostasis
Dihydrolipoyllysine-residue succinyltransferase
component of 2-oxoglutarate dehydrogenase
complex, mitochondrial
ODO2_HUMAN 3 6 48.6 9.01 Tricarboxylic acid cycle
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Electron transfer flavoprotein subunit alpha,
mitochondrial
ETFA_HUMAN 3 7 35.1 8.62 Electron transport
Electron transfer flavoprotein subunit beta ETFB_HUMAN 2 3 27.8 8.25 Electron transport
Endoplasmin ENPL_HUMAN 16 31 92.4 4.76 ER-associated protein catabolic process;
protein folding/transport; response to
hypoxia
Enoyl-CoA hydratase, mitochondrial ECHM_HUMAN 3 12 31.4 8.34 Fatty acid metabolism; Lipid metabolism
ERO1-like protein alpha precursor ERO1A_HUMAN 2 3 54.4 5.48 Electron transport
Glucosidase 2 subunit beta GLU2B_HUMAN 2 5 59.4 4.33 ER protein kinase cascade
Glutamate dehydrogenase 1, mitochondrial DHE3_HUMAN 2 2 61.4 7.66 Glutamate metabolism
Glyceraldehyde-3-phosphate dehydrogenase G3P_HUMAN 2 2 36 8.57 Glycolysis
Glycerol-3-phosphate dehydrogenase,
mitochondrial
GPDM_HUMAN 2 4 80.8 7.23 Glycolysis
Heme oxygenase 2 HMOX2_HUMAN 2 4 36 5.31 Heme oxidation; Oxidation reduction;
Response to hypoxia
Hexokinase-1 HXK1_HUMAN 2 3 102.4 6.36 Glycolysis
L-2-hydroxyglutarate dehydrogenase,
mitochondrial
L2HDH_HUMAN 2 2 50.3 8.57 Cellular protein metabolic process;
Oxidation reduction
Lon protease homolog, mitochondrial LONM_HUMAN 2 2 106.4 6.01 Required for intramitochondrial proteolysis
Long-chain-fatty-acid–CoA ligase 3 ACSL3_HUMAN 2 3 80.4 8.65 Fatty acid metabolism; Lipid metabolism
Long-chain-fatty-acid–CoA ligase 4 ACSL4_HUMAN 2 3 79.1 8.66 Fatty acid metabolism; Lipid metabolism
Malate dehydrogenase, mitochondrial MDHM_HUMAN 3 4 35.5 8.92 TCA glycolysis
Medium-chain specific acyl-CoA dehydrogenase,
mitochondrial
ACADM_HUMAN| 2 3 46.6 8.61 Fatty acid metabolism; Lipid metabolism
Methylenetetrahydrofolate reductase MTHR_HUMAN 2 2 74.5 5.22 Methionine metabolic process; Oxidation
reduction
Mitochondrial 2-oxoglutarate/malate carrier
protein
M2OM_HUMAN 2 2 34 9.92 Transport
Mitochondrial import receptor subunit TOM40
homolog
TOM40_HUMAN 3 3 37.9 6.79 Ion transport; Protein transport
Neutral alpha-glucosidase AB GANAB_HUMAN 7 10 106.8 5.74 Carbohydrate metabolic process
Neutral cholesterol ester hydrolase 1 ADCL1_HUMAN 2 4 45.8 6.76 Lipid degradation
Ornithine aminotransferase, mitochondrial
precursor
OAT_HUMAN 4 6 48.5 6.57 Mitochondrial matrix protein binding
Phosphoenolpyruvate carboxykinase,
mitochondrial
PPCKM_HUMAN 2 3 70.6 7.56 Gluconeogenesis
Protein disulfide-isomerase PDIA1_HUMAN 8 14 57.1 4.76 Cell redox homeostasis
Protein disulfide-isomerase A3 PDIA3_HUMAN 16 25 56.7 5.98 Cell redox homeostasis
Protein disulfide-isomerase A4 PDIA4_HUMAN 7 11 72.9 4.96 Cell redox homeostasis; Protein secretion
Protein disulfide-isomerase A6 PDIA6_HUMAN 2 4 48.1 4.95 Cell redox homeostasis; Protein folding
Pyruvate kinase isozymes M1/M2 KPYM_HUMAN 5 7 57.9 7.96 Glycolysis; Programmed cell death
Serine hydroxymethyltransferase, mitochondrial
precursor
GLYM_HUMAN 2 4 56 8.76 L-serine metabolic process; Glycine
metabolic process; One-carbon metabolic
process
Sterol regulatory element-binding protein 2 SRBP2_HUMAN 2 2 123.6 8.72 Cholesterol metabolism; Lipid metabolism;
Steroid metabolism;
Succinate dehydrogenase flavoprotein subunit,
mitochondrial
DHSA_HUMAN 3 10 72.6 7.06 Electron transport; Tricarboxylic acid cycle
Succinyl-CoA:3-ketoacid-coenzyme A transferase
1
SCOT_HUMAN 2 5 56.1 7.13 Ketone body catabolic process
Sulfide:quinone oxidoreductase, mitochondrial SQRD_HUMAN 6 9 49.9 9.18 Oxidation reduction
Superoxide dismutase [Mn], mitochondrial SODM_HUMAN 2 5 24.7 8.35 Elimination of radicals
Transmembrane emp24 domain-containing
protein 10
TMEDA_HUMAN 2 3 25 6.98 ER-Golgi protein transport
Trifunctional enzyme subunit alpha,
mitochondrial
ECHA_HUMAN 4 7 82.9 9.16 Fatty acid metabolism; Lipid metabolism
Trifunctional enzyme subunit beta, mitochondrial ECHB_HUMAN 2 4 51.3 9.45 Fatty acid metabolism
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AsPC-1
Ras-related protein Rab-1B 3 7 22.2 RAB1B_HUMAN VVDNTTAKEF ADSLGIPFLE TSAK
VVDNTTAKEF ADSLGIPFLE TSAK
EFADSLGIPF LETSAK
EFADSLGIPF LETSAK
EFADSLGIPF LETSAK
EFADSLGIPF LETSAK
NATNVEQAFM TMAAEIK
Ras-related protein Rab-7a 3 5 23.5 RAB7A_HUMAN DPENFPFVVL GNKIDLENR
DPENFPFVVL GNKIDLENR
DPENFPFVVL GNK
EAINVEQAFQ TIAR
EAINVEQAFQ TIAR
Ras-related protein Rab-1A 3 7 22.7 RAB1A_HUMAN VVDYTTAKEF ADSLGIPFLE TSAK
VVDYTTAKEF ADSLGIPFLE TSAK
EFADSLGIPF LETSAK
EFADSLGIPF LETSAK
EFADSLGIPF LETSAK
EFADSLGIPF LETSAK
NATNVEQSFM TMAAEIK
Ras-related protein Rab-10; 2 6 22.5 8.58 RAB10_HUMAN LLLIGDSGVG K
LLLIGDSGVG K
AFLTLAEDIL R
AFLTLAEDIL R
AFLTLAEDIL R
AFLTLAEDIL R
Ras-related protein Rab-2A 3 3 23.5 6.08 RAB2A_HUMAN YIIIGDTGVG K
TASNVEEAFI NTAK
IGPQHAATNA THAGNQGGQQ AGGGCC
Ras GTPase-activating-like protein IQGAP1 2 2 189.1 IQGA1_HUMAN ILAIGLINEA LDEGDAQK
FQPGETLTEI LETPATSEQE AEHQR
Transforming protein RhoA 2 3 21.8 RHOA_HUMAN QVELALWDTA GQEDYDR
QVELALWDTA GQEDYDR
HFCPNVPIIL VGNKK
BxPC-3
Ras-related protein Rab-2A 2 3 23.5 6.08 RAB2A_HUMAN GAAGALLVYD ITR
TASNVEEAFI NTAK
TASNVEEAFI NTAK
Ras-related protein Rab-1B 3 8 22.2 5.55 RAB1B_HUMAN VVDNTTAKEF ADSLGIPFLE TSAK
VVDNTTAKEF ADSLGIPFLE TSAK
VVDNTTAKEF ADSLGIPFLE TSAK
EFADSLGIPF LETSAK
EFADSLGIPF LETSAK
EFADSLGIPF LETSAK
EFADSLGIPF LETSAK
NATNVEQAFM TMAAEIK
Ras-related protein Rab-7a 2 3 23.5 6.39 RAB7A_HUMAN DPENFPFVVL GNK
EAINVEQAFQ TIAR
EAINVEQAFQ TIAR
Ras-related protein Rab-14 2 2 23.9 5.85 RAB14_HUMAN TGENVEDAFL EAAKK
TGENVEDAFL EAAK
Liu et al. Journal of Biomedical Science 2010, 17:74
http://www.jbiomedsci.com/content/17/1/74
Page 11 of 13adhesion molecule 1, CEA-related cell adhesion molecule
6, 4F2 cell-surface antigen heavy chain (a.k.a., CD98), epi-
dermal growth factor receptor (EGFR), hypoxia up-regu-
lated protein 1, MUC16 and mTOR, which may be further
verified in clinical specimens as biomarkers for PDAC.
In summary, we have demonstrated a proteomic
approach for analysis and identification of membrane
proteins in primary and metastatic PDAC cells. Many of
the identified proteins are known to be modulators of
cell-to-cell adhesion and tumor cell invasion. With the
potential targets derived from the present study, we will
next focus on promising candidates and explore their
functional role in cell proliferation, apoptosis or metabo-
lism in PDAC. Similar membrane proteomics approach
can be applied to tissue specimens from patients with
primary and metastatic tumors to reveal membrane pro-
tein targets for prognostic application or therapeutic
intervention.
Additional material
Additional file 1: Membrane and membrane-associated proteins
identified in AsPC-1 cells (Table S1) and BxPC-3 cells (Table S2).
Highlighted proteins were only found in AsPC-1 cells (Table S1) and
BxPC-3 cells (Table S2).
Author details
1UCLA School of Dentistry & Dental Research Institute, Los Angeles, CA,
90095, USA.
2UCLA Center of Excellence in Pancreatic Diseases, Los Angeles,
CA 90095, USA.
3UCLA Jonsson Comprehensive Cancer Center, Los Angeles,
CA 90095, USA.
Authors’ contributions
SH conceived of the study, participated in its design and coordination and
drafted the manuscript. XJL and MZ participated in the study design and
collected the data. VLWG participated in the study design and critically
reviewed the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 5 May 2010 Accepted: 13 September 2010
Published: 13 September 2010
References
1. Hines OJ, Reber HA: Pancreatic neoplasms. Curr Opin Gastroenterol 2004,
20(5):452-458.
2. Jaffee EM, Hruban RH, Canto M, Kern SE: Focus on pancreas cancer. Cancer
Cell 2002, 2(1):25-28.
3. Real FX: A “catastrophic hypothesis” for pancreas cancer progression.
Gastroenterol 2003, 124(7):1958-1964.
4. Amado RG, Rosen LS, Hecht JR, Lin LS, Rosen PJ: Low-dose trimetrexate
glucuronate and protracted 5-fluorouracil infusion in previously
untreated patients with advanced pancreatic cancer. Ann Oncol 2002,
13(4):582-588.
5. Wu CC, MacCoss MJ, Howell KE, Yates JR: A method for the
comprehensive proteomic analysis of membrane proteins. Nat Biotech
2003, 21(5):532-538.
6. Wu CC, Yates JR: The application of mass spectrometry to membrane
proteomics. Nat Biotech 2003, 21(3):262-267.
7. Dowling P, Meleady P, Dowd A, Henry M, Glynn S, Clynes M: Proteomic
analysis of isolated membrane fractions from superinvasive cancer cells.
Biochim Biophys Acta 2007, 1774(1):93-101.
8. Liang X, Zhao J, Hajivandi M, Wu R, Tao J, Amshey JW, Pope RM:
Quantification of Membrane and Membrane-Bound Proteins in Normal
and Malignant Breast Cancer Cells Isolated from the Same Patient with
Primary Breast Carcinoma. J Proteome Res 2006, 5(10):2632-2641.
9. Stockwin LH, Blonder J, Bumke MA, Lucas DA, Chan KC, Conrads TP,
Issaq HJ, Veenstra TD, Newton DL, Rybak SM: Proteomic Analysis of
Plasma Membrane from Hypoxia-Adapted Malignant Melanoma.
J Proteome Res 2006, 5(11):2996-3007.
10. Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, Pickren JW,
Berjian R, Douglass HO Jr, Chu TM: Characterization of a new primary
human pancreatic tumor line. Cancer Invest 1986, 4(1):15-23.
11. Tan M, Chu T: Characterization of the tumorigenic and metastatic
properties of a human pancreatic tumor cell line (AsPC-1) implanted
orthotopically into nude mice. Tumour Biol 1985, 6(1):89-98.
12. Deer EL, González-Hernández J, Coursen JD, Shea JE, Ngatia J, Scaife CL,
Firpo MA, Mulvihill SJ: Phenotype and genotype of pancreatic cancer cell
lines. Pancreas 2010, 39(4):425-35.
13. Nunomura K, Nagano K, Itagaki C, Taoka M, Okamura N, Yamauchi Y,
Sugano S, Takahashi N, Izumi T, Isobe T: Cell surface labeling and mass
spectrometry reveal diversity of cell surface markers and signaling
molecules expressed in undifferentiated mouse embryonic stem cells.
Mol Cell Proteomics 2005, 4(12):1968-1976.
14. Zhang L, Lun Y, Yan D, Yu L, Ma W, Du B, Zhu X: Proteomic analysis of
macrophages: A new way to identify novel cell-surface antigens.
J Immunol Methods 2007, 321(1-2):80-85.
15. Shi X, Friess H, Kleeff J, Ozawa F, Büchler MW: Pancreatic Cancer: Factors
Regulating Tumor Development, Maintenance and Metastasis. Pancreatol
2001, 1(5):517-524.
16. Keith B, Simon MC: Hypoxia-Inducible Factors, Stem Cells, and Cancer.
Cell 2007, 129(3):465-472.
17. Nelson DA, Tan TT, Rabson AB, Anderson D, Degenhardt K, White E:
Hypoxia and defective apoptosis drive genomic instability and
tumorigenesis. Genes Dev 2004, 18(17):2095-2107.
18. Olson P, Hanahan D: Breaching the Cancer Fortress. Science 2009,
324(5933):1400-1401.
19. Kurahara H, Takao S, Maemura K, Shinchi H, Natsugoe S, Aikou T: Impact of
Vascular Endothelial Growth Factor-C and -D Expression in Human
Pancreatic Cancer. Clin Cancer Res 2004, 10(24):8413-8420.
20. Pàez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Viñals F, Inoue M,
Bergers G, Hanahan D, Casanovas O: Antiangiogenic Therapy Elicits
Malignant Progression of Tumors to Increased Local Invasion and
Distant Metastasis. Cancer Cell 2009, 15(3):220-231.
Table 4 A list of small G proteins identified in AsPC-1 and BxPC-3 cells (Continued)
Cell division control protein 42 homolog 2 3 21.3 5.76 CDC42_HUMAN TPFLLVGTQI DLRDDPSTIE K
TPFLLVGTQI DLRDDPSTIE K
TPFLLVGTQI DLR
Guanine nucleotide-binding protein subunit beta-2 2 4 37.3 5.6 GBB2_HUMAN SELEQLRQEA EQLR
SELEQLRQEA EQLR
KACGDSTLTQ ITAGLDPVGR
KACGDSTLTQ ITAGLDPVGR
Liu et al. Journal of Biomedical Science 2010, 17:74
http://www.jbiomedsci.com/content/17/1/74
Page 12 of 1321. Büchler P, Reber HA, Lavey RS, Tomlinson J, Büchler MW, Friess H, Hines OJ:
Tumor hypoxia correlates with metastatic tumor growth of pancreatic
cancer in an orthotopic murine model1. JS u r gR e s2004, 120(2):295-303.
22. Walsh N, O’Donovan N, Kennedy S, Henry M, Meleady P, Clynes M,
Dowling P: Identification of pancreatic cancer invasion-related proteins
by proteomic analysis. Proteome Sci 2009, 7(1):3.
23. Cui Y, Wu J, Zong M, Song G, Jia Q, Jiang J, Han J: Proteomic profiling in
pancreatic cancer with and without lymph node metastasis. Int J Cancer
2009, 124(7):1614-1621.
24. Roda O, Chiva C, Espuña G, Gabius HJ, Real FX, Navarro P, Andreu D: A
proteomic approach to the identification of new tPA receptors in
pancreatic cancer cells. Proteomics 2006, 6(S1):S36-S41.
25. Rathinam R, Alahari S: Important role of integrins in the cancer biology.
Cancer Metastasis Rev 2010, 29(1):223-237.
26. Ryschich E, Khamidjanov A, Kerkadze V, Buchler MW, Zoller M, Schmidt J:
Promotion of tumor cell migration by extracellular matrix proteins in
human pancreatic cancer. Pancreas 2009, 38(7):804-810.
27. Fukushi Ji, Makagiansar IT, Stallcup WB: NG2 proteoglycan promotes
endothelial cell motility and angiogenesis via engagement of galectin-3
and alpha 3 beta 1 Integrin. Mol Biol Cell 2004, 15(8):3580-3590.
28. Künzli B, Berberat P, Zhu Z, Martignoni M, Kleeff J, Tempia-Caliera A,
Fukuda M, Zimmermann A, Friess H, Büchler M: Influences of the
lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2
binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma.
Cancer 2002, 94(1):228-239.
29. Kobayashi S, Kishimoto T, Kamata S, Otsuka M, Miyazaki M, Ishikura H:
Rapamycin, a specific inhibitor of the mammalian target of rapamycin,
suppresses lymphangiogenesis and lymphatic metastasis. Cancer Sci
2007, 98(5):726-733.
30. Benmerah A, Scott M, Poupon V, Marullo S: Nuclear Functions for Plasma
Membrane-Associated Proteins? Traffic 2003, 4(8):503-511.
31. Ludwig JA, Weinstein JN: Biomarkers in Cancer Staging, Prognosis and
Treatment Selection. Nat Rev Cancer 2005, 5(11):845-856.
32. Harsha HC, Kandasamy K, Ranganathan P, Rani S, Ramabadran S,
Gollapudi S, Balakrishnan L, Dwivedi SB, Telikicherla D, Selvan LD, Goel R,
Mathivanan S, Marimuthu A, Kashyap M, Vizza RF, Mayer RJ, Decaprio JA,
Srivastava S, Hanash SM, Hruban RH, Pandey A: A Compendium of
Potential Biomarkers of Pancreatic Cancer. PLoS Med 2009, 6(4):e1000046.
33. Grote T, Logsdon CD: Progress on molecular markers of pancreatic
cancer. Curr Opin Gastroenterol 2007, 23(5):508-514.
34. Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M: KAI1
expression is up-regulated in early pancreatic cancer and decreased in
the presence of metastases. Cancer Res 1996, 56:4876-4880.
35. Gold DV, Modrak DE, Ying Z, Cardillo TM, Sharkey RM, Goldenberg DM:
New MUC1 Serum Immunoassay Differentiates Pancreatic Cancer From
Pancreatitis. J Clin Oncol 2006, 24(2):252-258.
36. Simeone DM, Ji B, Banerjee M, Arumugam T, Li D, Anderson MA,
Bamberger AM, Greenson J, Brand RE, Ramachandran V, Logsdon CD:
CEACAM1, a Novel Serum Biomarker for Pancreatic Cancer. Pancreas
2007, 34(4).
37. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M: Most
human carcinomas of the exocrine pancreas contain mutant c-K-ras
genes. Cell 1988, 53(4):549-554.
38. DiMagno E, Malagelada J, Moertel C, Go V: Prospective evaluation of the
pancreatic secretion of immunoreactive carcinoembryonic antigen,
enzyme, and bicarbonate in patients suspected of having pancreatic
cancer. Gastroenterology 1977, 73(3):457-461.
39. Ritts RJ, Del Villano B, Go V, Herberman R, Klug T, Zurawski VJ: Initial clinical
evaluation of an immunoradiometric assay for CA 19-9 using the NCI
serum bank. Int J Cancer 1984, 33(3):339-345.
40. Pignatelli M, Durbin H, Bodmer W: Carcinoembryonic antigen functions as
an accessory adhesion molecule mediating colon epithelial cell-collagen
interactions. Proc Natl Acad Sci USA 1990, 87(4):1541-1545.
doi:10.1186/1423-0127-17-74
Cite this article as: Liu et al.: Membrane proteomic analysis of
pancreatic cancer cells. Journal of Biomedical Science 2010 17:74.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Liu et al. Journal of Biomedical Science 2010, 17:74
http://www.jbiomedsci.com/content/17/1/74
Page 13 of 13